Neuropeptide Y Blood Levels Predict Atrial Fibrillation After Heart Bypass Surgery
Higher pre-surgery neuropeptide Y (NPY) levels independently predicted postoperative atrial fibrillation in 120 patients undergoing off-pump coronary bypass surgery.
Quick Facts
What This Study Found
Pre-surgical plasma NPY levels independently predicted POAF (OR 1.055 per unit increase, P=0.041) alongside age (OR 1.135) and left atrial size (OR 1.136) in multivariable analysis. NPY was significantly higher in the POAF group (31.72 vs 27.95, P=0.014).
Key Numbers
Patients were enrolled from January 1 to May 31, 2020, undergoing isolated off-pump CABG with NPY measurements.
How They Did This
Prospective cohort study of 120 consecutive patients undergoing isolated off-pump CABG (January-May 2020). Pre-operative plasma NPY measured by ELISA. POAF detected by 7-day Holter monitoring. Multivariable logistic regression for independent predictors.
Why This Research Matters
A simple blood test measuring NPY levels before heart surgery could identify patients at high risk for postoperative atrial fibrillation, enabling preventive interventions that reduce complications, hospital stays, and stroke risk.
The Bigger Picture
NPY is one of the most abundant neuropeptides in the cardiovascular system. This study connects NPY to cardiac autonomic regulation and arrhythmia risk, suggesting that neuropeptide signaling plays a direct role in post-surgical heart rhythm stability. It adds to growing evidence that neuropeptide biomarkers could transform surgical risk assessment.
What This Study Doesn't Tell Us
Single-center study with 120 patients during a 5-month period. The modest odds ratio for NPY (1.055) suggests it adds incremental value but is not a strong standalone predictor. Association does not prove causation. Heart rate variability correlations were weak-to-moderate. External validation in larger cohorts needed.
Questions This Raises
- ?Would interventions to lower NPY levels or block NPY signaling before surgery reduce postoperative AFib?
- ?Can NPY be combined with other biomarkers for a more accurate AFib risk prediction panel?
- ?Does elevated NPY predict AFib risk in other cardiac surgery types beyond off-pump CABG?
Trust & Context
- Key Stat:
- 27.5% developed AFib after bypass surgery, with elevated pre-surgical NPY levels independently predicting who would develop this complication
- Evidence Grade:
- Moderate evidence: prospective cohort with multivariable analysis and objective outcome assessment (7-day Holter), but single center with modest sample size.
- Study Age:
- Published in 2024 using data from 2020. Pre-COVID surgical cohort.
- Original Title:
- Circulating neuropeptide Y as a biomarker in postoperative atrial fibrillation cases administered off-pump coronary bypass Graft surgery.
- Published In:
- Heliyon, 10(10), e31251 (2024)
- Authors:
- Zhang, Jian(5), He, Yuanchen, Yin, Zongtao, Li, Rui, Zhang, Xiaohui, Wang, Yang, Wang, Huishan
- Database ID:
- RPEP-09639
Evidence Hierarchy
Frequently Asked Questions
What is neuropeptide Y and what does it do in the heart?
NPY is one of the most abundant neuropeptides in the cardiovascular system. It helps regulate the autonomic nervous system that controls heart rate and rhythm. Higher NPY levels may indicate increased sympathetic nervous system activity that predisposes to irregular heart rhythms.
Could a blood test predict AFib after surgery?
This study suggests measuring NPY before surgery could help identify patients at risk for postoperative atrial fibrillation. Combined with other risk factors like age and heart size, it could improve pre-surgical risk assessment and enable preventive measures.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09639APA
Zhang, Jian; He, Yuanchen; Yin, Zongtao; Li, Rui; Zhang, Xiaohui; Wang, Yang; Wang, Huishan. (2024). Circulating neuropeptide Y as a biomarker in postoperative atrial fibrillation cases administered off-pump coronary bypass Graft surgery.. Heliyon, 10(10), e31251. https://doi.org/10.1016/j.heliyon.2024.e31251
MLA
Zhang, Jian, et al. "Circulating neuropeptide Y as a biomarker in postoperative atrial fibrillation cases administered off-pump coronary bypass Graft surgery.." Heliyon, 2024. https://doi.org/10.1016/j.heliyon.2024.e31251
RethinkPeptides
RethinkPeptides Research Database. "Circulating neuropeptide Y as a biomarker in postoperative a..." RPEP-09639. Retrieved from https://rethinkpeptides.com/research/zhang-2024-circulating-neuropeptide-y-as
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.